Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity
Clinical and experimental data have highlighted the important role of the immune cell function and composition in determining tumor progression or eradication (1, 2). While a high prevalence of tumor-infiltrating T cells is associated with improved …